Numans Health Food Holdings Company Limited (HK:2530)
:2530
Want to see HK:2530 full AI Analyst Report?
Top Page
Numans Health Food Holdings Company Limited
(2530)
Select Model
Select Model
Rating:61Neutral
Price Target:
HK$0.69
ā²(16.27% Upside)
Action:Reiterated
Date:05/27/26
The score is held back primarily by a major 2025 profitability and revenue step-down, partially offset by a very strong low-debt balance sheet and still-solid cash generation. Technicals are supportive with the price above key moving averages, but momentum looks overextended. Valuation is mixed, with a high dividend yield offset by a high P/E amid weakened earnings.
Positive Factors
Conservative balance sheet
The companyās extremely low leverage and large equity base materially reduce solvency and refinancing risk. That balance sheet flexibility supports durable capacity to fund operations, dividends or opportunistic investments during downturns without pressuring liquidity or credit metrics.
Negative Factors
Sharp revenue decline
A 24% revenue drop signals significant loss of sales scale or demand and impairs fixed-cost absorption. If sustained, smaller top line reduces bargaining power, compresses operating leverage, and makes durable margin recovery and growth harder without clear restoration of distribution or demand.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
The companyās extremely low leverage and large equity base materially reduce solvency and refinancing risk. That balance sheet flexibility supports durable capacity to fund operations, dividends or opportunistic investments during downturns without pressuring liquidity or credit metrics.
Read all positive factors
Numans Health Food Holdings Company Limited (2530) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$680.00M
Dividend Yield8.95%
Average Volume (3M)43.20K
Price to Earnings (P/E)107.6
Beta (1Y)0.23
Revenue Growth-31.74%
EPS Growth-92.61%
CountryHK
Employees44
SectorConsumer Goods
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,000,000,000
10 Day Avg. Volume61,600
30 Day Avg. Volume43,200
Financial Highlights & Ratios
PEG Ratio-1.11
Price to Book (P/B)1.12
Price to Sales (P/S)3.00
P/FCF Ratio11.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Numans Health Food Holdings Company Limited Business Overview & Revenue Model
Company Description
Numans Health Food Holdings Company Limited engages in the marketing, sales, and distribution of finished nutritional products under the Nemans brand name in the People's Republic of China. It offers algal oil docosahexaenoic acid for development ...
Numans Health Food Holdings Company Limited Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
83
Very Positive
Cash Flow
68
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 184.44M | 277.50M | 426.55M | 367.30M | 337.61M |
| Gross Profit | 122.78M | 211.06M | 320.87M | 273.19M | 246.60M |
| EBITDA | 14.05M | 103.76M | 199.86M | 103.60M | 157.81M |
| Net Income | 5.36M | 74.90M | 159.34M | 87.52M | 119.67M |
Balance Sheet | |||||
| Total Assets | 513.74M | 415.59M | 470.02M | 403.58M | 288.81M |
| Cash, Cash Equivalents and Short-Term Investments | 401.65M | 235.82M | 262.56M | 192.84M | 152.66M |
| Total Debt | 3.77M | 4.43M | 5.83M | 7.45M | 1.23M |
| Total Liabilities | 18.40M | 39.07M | 59.94M | 156.34M | 86.29M |
| Stockholders Equity | 495.34M | 376.52M | 410.08M | 247.24M | 202.52M |
Cash Flow | |||||
| Free Cash Flow | 46.71M | 82.33M | 149.95M | 39.42M | 93.00M |
| Operating Cash Flow | 46.75M | 83.46M | 150.57M | 44.31M | 93.99M |
| Investing Cash Flow | -37.02K | 2.04M | 1.57M | -4.14M | -519.00K |
| Financing Cash Flow | 116.27M | -113.48M | -83.79M | -8.55M | -29.31M |
Numans Health Food Holdings Company Limited Technical Analysis
Negative
0.59
Price Trends
0.60
Negative
0.63
Negative
Market Momentum
>-0.01
Negative
51.32
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2530, the sentiment is Negative. The current price of 0.59 is below the 20-day moving average (MA) of 0.59, below the 50-day MA of 0.60, and equal to the 200-day MA of ā, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 51.32 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2530.
Numans Health Food Holdings Company Limited Peers Comparison
UnderperformOutperform
Sector (57)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
88 Outperform | HK$3.20B | 12.85 | 12.93% | 3.74% | 22.72% | 41.32% | |
75 Outperform | HK$1.22B | 8.33 | 5.61% | 10.44% | -1.52% | 6.08% | |
66 Neutral | HK$214.29M | 12.64 | 4.03% | 47.72% | 2.05% | 37.85% | |
61 Neutral | HK$680.00M | 107.59 | 1.08% | 8.95% | -31.74% | -92.61% | |
57 Neutral | HK$345.00M | 18.45 | 3.94% | 0.78% | 6.35% | -52.30% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% | |
56 Neutral | HK$990.11M | 4.65 | 4.38% | 5.38% | -11.88% | -61.92% |
* Consumer Goods Sector Average
HK:2530
Numans Health Food Holdings Company Limited
0.70
0.11
18.64%
HK:0926
Besunyen Holdings Co. Ltd.
2.45
0.38
18.24%
HK:1767
TS Wonders Holding Limited
0.34
0.03
8.06%
HK:1837
Natural Food International Holding Ltd.
1.45
0.79
121.04%
HK:2317
Vedan International (Holdings) Ltd.
0.73
0.20
36.96%
HK:3838
China Starch Holdings Limited
0.17
<0.01
0.60%
Numans Health Food Holdings Company Limited Corporate Events
Numans Health Food Seeks Mandate to Sell Remaining Lenovo Stake
May 26, 2026
Numans Health Food Holdings Company plans to secure a mandate allowing its directors to dispose of up to all 4,000,000 Lenovo Group shares it currently holds during a defined mandate period. The move follows the sale of 6,000,000 Lenovo shares ove...
Numans Health Food realises Lenovo stake to boost liquidity
May 22, 2026
Numans Health Food Holdings said it has sold 6,000,000 shares of Lenovo Group on the open market for about HK$89.7 million, at an average price of roughly HK$14.95 per share. Following the transaction, its stake in Lenovo falls to 4,000,000 shares...
Numans Health Food Calls 2026 AGM, Proposes Dividend and Share Mandates
May 21, 2026
Numans Health Food Holdings Company Limited has called its annual general meeting for 15 June 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended 31 December 2025 and consider a final dividend of H...
Numans Health Food Announces Final Cash Dividend for 2025
May 4, 2026
Numans Health Food Holdings Company Limited has declared a final ordinary cash dividend of HKD 0.025 per share for the financial year ended 31 December 2025, subject to shareholder approval on 15 June 2026. The dividend will be paid in Hong Kong d...
Numans Health Food Posts Sharp Profit Drop but Maintains Dividend for 2025
Apr 30, 2026
Numans Health Food Holdings Company Limited reported a sharp downturn in its 2025 annual results, with revenue falling 31.8% to RMB189.3 million and gross profit slipping accordingly. The company’s profitability weakened significantly, as pr...
Numans Health Food Details Chronology Behind Auditor Change Decision
Apr 29, 2026
Numans Health Food Holdings Company Limited has provided additional details on its recent change of auditor following earlier announcements about delays to its 2025 annual results, possible postponement of its 2025 annual report and the suspension...
Numans Health Food Issues Profit Warning as China Headwinds Hit Earnings
Apr 23, 2026
Numans Health Food Holdings warned that its profit after tax for 2025 is expected to fall sharply to no more than about RMB6.0 million, compared with approximately RMB74.9 million a year earlier. The board attributes the downturn mainly to a broad...
Numans Health Food Sets April Board Meeting as Trading Suspension Continues
Apr 20, 2026
Numans Health Food Holdings Company Limited has scheduled a board meeting for 30 April 2026 to consider and approve its audited annual results for the year ended 31 December 2025. The board will also deliberate on the potential declaration of a fi...
Numans Health Food Shifts to Innovax as Compliance Adviser to Cut Costs
Apr 17, 2026
Numans Health Food Holdings Company Limited, a Cayman Islands-incorporated health food producer listed in Hong Kong, offers health-focused food products to consumers in its core markets. The company operates within Hong Kong’s regulated capi...
Numans Health Food Warns of Audit-Driven Delay to 2025 Results and Reporting
Apr 1, 2026
Numans Health Food Holdings Company Limited has announced a delay in publishing its audited annual results for the year ended 31 December 2025, citing the need for additional time by its new auditor to complete the 2025 annual audit. The company h...
Numans Health Food Replaces Compliance Adviser Amid Fee Dispute
Mar 9, 2026
Numans Health Food Holdings Company Limited, a Cayman Islands–incorporated health food company listed in Hong Kong, focuses on providing nutrition and wellness products to consumers in its core markets. Its shares trade on the Main Board of ...
Numans Health Food Buys HK$19.7 Million Stake in AIāDriven R&D Firm XtalPi
Mar 4, 2026
Numans Health Food Holdings has expanded its investment portfolio with the open‑market purchase of 2,000,000 shares in XtalPi for about HK$19.73 million, funded entirely from internal resources rather than IPO proceeds. The transaction, whic...
Numans Health Food switches auditors, warns of possible delay in 2025 results
Mar 3, 2026
Numans Health Food Holdings Company Limited announced that its auditor, Crowe (HK) CPA Limited, has resigned effective 3 March 2026 after the parties failed to reach agreement on a proposed audit fee increase for the 2025 financial year. The highe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.